For instance, a study by Liao et al. [51] investigated the use of transferrin-conjugated nanoparticles to deliver siRNA specifically targeting BACE1, a critical enzyme in producing Aβ, demonstrating successful delivery and therapeutic effects in a mouse model of AD. This evidence concerns the gene TF and Alzheimer disease.